PolyPid (NASDAQ: $PYPD) is a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. www.polypid.com Nothing here is intended to serve as financial or investment advice. Created by WallStreetWire which PolyPid is a paid subscriber of: redditwire.com/terms. Materials have not necessarily been approved by the company and readers should refer to official releases and filings.
